{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:44Z","timestamp":1786985084555,"version":"build-2736575974"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100032767","name":"Sichuan Medical Association","doi-asserted-by":"publisher","award":["S23073"],"award-info":[{"award-number":["S23073"]}],"id":[{"id":"10.13039\/100032767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["24NSFSC6545"],"award-info":[{"award-number":["24NSFSC6545"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,304,558"],"award-info":[{"award-number":["82,304,558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117499","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:51:06Z","timestamp":1761403866000},"page":"117499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Targeting glycolytic enzymes to combat cancer metastasis: Strategies toward clinical translation"],"prefix":"10.1016","volume":"243","author":[{"given":"Dan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117499_b0005","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49.","DOI":"10.3322\/caac.21820"},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0015","first-page":"1564","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Metastasis. Cell."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0020","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","article-title":"Better together: circulating tumor cell clustering in metastatic cancer","volume":"7","author":"Schuster","year":"2021","journal-title":"Trends Cancer."},{"issue":"7","key":"10.1016\/j.bcp.2025.117499_b0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41419-021-03890-7","article-title":"Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis","volume":"12","author":"Deng","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-019-1194-z","article-title":"PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma","volume":"38","author":"Feng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0045","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1111\/jcmm.13732","article-title":"Aldolase a as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer","volume":"22","author":"Jiang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J. Pathol."},{"issue":"15","key":"10.1016\/j.bcp.2025.117499_b0055","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","article-title":"100 years of the Warburg effect: a cancer metabolism endeavor","volume":"187","author":"Fendt","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0060","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s42255-023-00927-3","article-title":"A century of the Warburg effect","volume":"5","author":"Thompson","year":"2023","journal-title":"Nat Metab."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Taddei","year":"2012","journal-title":"J. Pathol."},{"issue":"2 Pt A","key":"10.1016\/j.bcp.2025.117499_b0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.bcp.2025.117499_b0080","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/MCB.06248-11","article-title":"Glucose oxidation modulates anoikis and tumor metastasis","volume":"32","author":"Kamarajugadda","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"3","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","article-title":"NAD+ metabolism, stemness, the immune response, and cancer","volume":"6","author":"Navas","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0105","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"22","key":"10.1016\/j.bcp.2025.117499_b0115","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1002\/cam4.4315","article-title":"The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: a two-center cohort study","volume":"10","author":"Bai","year":"2021","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/bjc.2016.413","article-title":"Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer","volume":"116","author":"Marmorino","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.106794","article-title":"Extracellular lactate as an alternative energy source for retinal bipolar cells","volume":"300","author":"Calbiague-Garcia","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","article-title":"The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment","volume":"10","author":"Zhang","year":"2022","journal-title":"Genes Dis."},{"issue":"7788","key":"10.1016\/j.bcp.2025.117499_b0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117499_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2025.117499_b0145","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","article-title":"Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-\u03baB\/IL-8 pathway that drives tumor angiogenesis","volume":"71","author":"V\u00e9gran","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1215\/15228517-2008-106","article-title":"Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2","volume":"11","author":"Baumann","year":"2009","journal-title":"Neuro Oncol."},{"issue":"20","key":"10.1016\/j.bcp.2025.117499_b0155","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1111\/j.1742-4658.2012.08748.x","article-title":"Knockdown of lactate dehydrogenase a suppresses tumor growth and metastasis of human hepatocellular carcinoma","volume":"279","author":"Sheng","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2025.117499_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101060","article-title":"Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effect","volume":"73","author":"Zhang","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2025.117499_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumor microenvironment: from immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110986","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells","volume":"39","author":"Gu","year":"2022","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumor microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0185","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002155","article-title":"Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a specific CEBPB Isoform in Triple-negative Breast Cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0195","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/med.21948","article-title":"Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds","volume":"43","author":"Ang","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2025.117499_b0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.04.005","article-title":"Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression","volume":"115","author":"Huang","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2015.04.025","article-title":"Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines","volume":"364","author":"Kondaveeti","year":"2015","journal-title":"Cancer Lett."},{"issue":"32","key":"10.1016\/j.bcp.2025.117499_b0215","doi-asserted-by":"crossref","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","article-title":"Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors","volume":"112","author":"Daemen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-015-0117-5","article-title":"Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K\/AKT pathway","volume":"8","author":"Fu","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b0225","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/cells11061041","article-title":"Tumor Cell Glycolysis-At the Crossroad of Epithelial-Mesenchymal transition and Autophagy","volume":"11","author":"Marcucci","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3892\/ijo.2016.3774","article-title":"Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression","volume":"50","author":"Liu","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0235","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/0008-5472.CAN-10-0965","article-title":"Phosphoglucose isomerase\/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells","volume":"71","author":"Ahmad","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0240","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10555-023-10120-3","article-title":"Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics","volume":"42","author":"Janin","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0245","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/cas.14524","article-title":"Aldolase a promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma","volume":"111","author":"Saito","year":"2020","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41419-022-04576-4","article-title":"PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4\/ERK signaling pathway and accelerating glycolysis","volume":"13","author":"He","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2020.12.015","article-title":"The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies","volume":"33","author":"Xu","year":"2021","journal-title":"Cell Metab."},{"issue":"18","key":"10.1016\/j.bcp.2025.117499_b0260","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.molcel.2021.08.031","article-title":"Moonlighting functions of metabolic enzymes and metabolites in cancer","volume":"81","author":"Pan","year":"2021","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0265","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tibs.2016.05.013","article-title":"Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription","volume":"41","author":"Boukouris","year":"2016","journal-title":"Trends Biochem. Sci"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0270","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","article-title":"Metabolic Kinases Moonlighting as Protein Kinases","volume":"43","author":"Lu","year":"2018","journal-title":"Trends Biochem. Sci"},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0275","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11427-021-1999-2","article-title":"Cancer metabolism and tumor microenvironment: fostering each other?","volume":"65","author":"Yuan","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0280","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","article-title":"Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer","volume":"69","author":"Liang","year":"2020","journal-title":"Gut"},{"issue":"43","key":"10.1016\/j.bcp.2025.117499_b0285","doi-asserted-by":"crossref","first-page":"15526","DOI":"10.1073\/pnas.1407717111","article-title":"Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition","volume":"111","author":"Hamabe","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0290","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1084\/jem.20190158","article-title":"Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis","volume":"216","author":"Dai","year":"2019","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.bcp.2025.117499_b0295","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/s41388-017-0086-y","article-title":"Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein","volume":"37","author":"Cheng","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","article-title":"Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment","volume":"65","author":"Barron","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0305","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.7150\/thno.32915","article-title":"Metastatic Colorectal Cancer Rewrites Metabolic Program through a Glut3-YAP-dependent Signaling Circuit","volume":"9","author":"Kuo","year":"2019","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0310","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40170-021-00248-7","article-title":"A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism","volume":"9","author":"Shriwas","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bcp.2025.117499_b0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","author":"Chan","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0325","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12987-023-00501-9","article-title":"Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line","volume":"20","author":"Ozg\u00fcr","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0330","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12967-021-03173-x","article-title":"TRIM38 triggers the uniquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer","volume":"19","author":"Wang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0335","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/cancers11010033","article-title":"Ovarian Cancer Relies on Glucose Transporter 1 to fuel Glycolysis and growth: Anti-Tumor activity of BAY-876","volume":"11","author":"Ma","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0345","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1158\/1535-7163.MCT-21-0925","article-title":"Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells","volume":"21","author":"Guo","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0350","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0355","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1158\/1535-7163.MCT-08-0569","article-title":"A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death","volume":"7","author":"Wood","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0360","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1038\/s41598-020-63232-z","article-title":"Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner","volume":"10","author":"Oca\u00f1a","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0365","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/s41467-022-30326-3","article-title":"Molecular basis for inhibiting human glucose transporters by exofacial inhibitors","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bcp.2025.117499_b0370","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jmb.2017.07.009","article-title":"A Glimpse of Membrane Transport through Structures-advances in the Structural Biology of the GLUT Glucose Transporters","volume":"429","author":"Yan","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"238","key":"10.1016\/j.bcp.2025.117499_b0375","article-title":"Design, synthesis of novel triptolide-glucose conjugates targeting glucose Transporter-1 and their selective antitumor effect","volume":"5","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0380","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.chembiol.2021.10.007","article-title":"Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors","volume":"29","author":"Olszewski","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0385","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1021\/acs.jmedchem.0c00897","article-title":"Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil","volume":"64","author":"Chang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2025.117499_b0390","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1182\/blood-2011-09-377846","article-title":"Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy","volume":"119","author":"McBrayer","year":"2012","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.bcp.2025.117499_b0395","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1073\/pnas.1603735113","article-title":"Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides","volume":"113","author":"Kapoor","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"229","key":"10.1016\/j.bcp.2025.117499_b0400","article-title":"Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia","volume":"5","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0405","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/acs.jmedchem.4c02717","article-title":"Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117499_b0410","article-title":"GLUT and HK: two primary and essential key players in Tumor glycolysis","volume":"15","author":"Yadav","year":"2024","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188457","article-title":"Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer","volume":"1874","author":"Tilekar","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0420","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jcmgh.2022.07.008","article-title":"Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer through Upregulating Bmi1-UPF1-HK2 Pathway","volume":"14","author":"Wu","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0425","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0430","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10120-022-01340-7","article-title":"Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK\/JUN\/HK2 axis regulated glycolysis","volume":"26","author":"Mi","year":"2023","journal-title":"Gastric Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0435","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/0008-5472.CAN-21-1820","article-title":"Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0440","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41419-022-04727-7","article-title":"TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells","volume":"13","author":"Tantai","year":"2022","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0445","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","article-title":"STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2","volume":"25","author":"Zhang","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117499_b0450","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cac2.12351","article-title":"A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability","volume":"42","author":"Wang","year":"2022","journal-title":"Cancer Commun (lond)."},{"issue":"14","key":"10.1016\/j.bcp.2025.117499_b0455","article-title":"Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion","volume":"12","author":"Lin","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0460","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.drudis.2022.05.017","article-title":"The development of small-molecule inhibitors targeting hexokinase 2","volume":"27","author":"Shan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2025.117499_b0465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2019.09.005","article-title":"Dietary 2-deoxy-D-glucose impairs tumor growth and metastasis by inhibiting angiogenesis","volume":"123","author":"Singh","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117499_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113801","article-title":"Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection","volume":"156","author":"Dey","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117499_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115029","article-title":"2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation","volume":"199","author":"Sun","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0480","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CM9.0000000000000577","article-title":"3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0485","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2025.117499_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113988","article-title":"3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells","volume":"177","author":"Sun","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0495","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.3390\/cancers12113332","article-title":"The potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment","volume":"12","author":"Huang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117499_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106740","article-title":"A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism","volume":"190","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"101","key":"10.1016\/j.bcp.2025.117499_b0505","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.actbio.2019.11.003","article-title":"Multi-responsive albumin-lonidamine conjugated hybridized gold nanoparticle as a combined photothermal-chemotherapy for synergistic tumor ablation","volume":"1","author":"Ruttala","year":"2020","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0510","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12951-023-02260-z","article-title":"Lonidamine liposomes to enhance photodynamic and photothermal therapy of hepatocellular carcinoma by inhibiting glycolysis","volume":"21","author":"Lei","year":"2023","journal-title":"J Nanobiotechnology."},{"issue":"13","key":"10.1016\/j.bcp.2025.117499_b0515","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1021\/acs.jmedchem.3c00118","article-title":"Degradation of Hexokinase 2 Blocks Glycolysis and Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death for Breast Cancer Therapy","volume":"66","author":"Sang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117499_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103609","article-title":"Structure based discovery of novel hexokinase 2 inhibitors","volume":"96","author":"Liu","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0525","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-017-0530-4","article-title":"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2","volume":"36","author":"Li","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117499_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105367","article-title":"Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis","volume":"164","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"264","key":"10.1016\/j.bcp.2025.117499_b0535","article-title":"Research progress of hexokinase 2 in inflammatory-related diseases and its inhibitors","volume":"15","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0540","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/molecules29010075","article-title":"The Promoting Role of HK II in Tumor Development and the Research Progress of its Inhibitors","volume":"29","author":"Liu","year":"2023","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0545","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1158\/0008-5472.CAN-06-3935","article-title":"Down-regulation of phosphoglucose isomerase\/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells","volume":"67","author":"Funasaka","year":"2007","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.bcp.2025.117499_b0550","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1158\/0008-5472.CAN-09-0488","article-title":"Phosphoglucose isomerase\/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer","volume":"69","author":"Funasaka","year":"2009","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.bcp.2025.117499_b0555","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1158\/0008-5472.CAN-07-1586","article-title":"Regulation of phosphoglucose isomerase\/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14","volume":"67","author":"Yanagawa","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0560","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1471-4159.1989.tb09178.x","article-title":"Effect of 6-phosphogluconate on phosphoglucose isomerase in rat brain in vitro and in vivo","volume":"52","author":"Gaitonde","year":"1989","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0565","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/cas.15713","article-title":"RNAi screening reveals a synthetic chemical-genetic interaction between ATP synthase and PFK1 in cancer cells","volume":"114","author":"Kobayashi","year":"2023","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0570","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10555-022-10027-5","article-title":"Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux","volume":"41","author":"Jones","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0575","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","article-title":"Roles of PFKFB3 in cancer","volume":"24","author":"Shi","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0580","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41419-018-0435-y","article-title":"PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT","volume":"9","author":"Shi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0585","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s40001-024-01808-5","article-title":"Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification","volume":"29","author":"Lu","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0590","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2079182","article-title":"Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer","volume":"11","author":"Zheng","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0595","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13578-024-01205-9","article-title":"PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies","volume":"14","author":"Liu","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bcp.2025.117499_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111184","article-title":"PFKFB3 regulates breast cancer tumorigenesis and Fulvestrant sensitivity by affecting ER\u03b1 stability","volume":"119","author":"Jia","year":"2024","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0605","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s41388-020-01621-4","article-title":"Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer","volume":"40","author":"Xiao","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0610","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.31868","article-title":"Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers","volume":"144","author":"Mondal","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2025.117499_b0615","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41419-019-1916-3","article-title":"PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses","volume":"10","author":"Sarkar Bhattacharya","year":"2019","journal-title":"Cell Death Dis."},{"issue":"965","key":"10.1016\/j.bcp.2025.117499_b0620","article-title":"Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy","volume":"15","author":"Cao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0625","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2016.01.054","article-title":"ALDOA functions as an oncogene in the highly metastatic pancreatic cancer","volume":"374","author":"Ji","year":"2016","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.bcp.2025.117499_b0630","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-18-4080","article-title":"Therapeutic Targeting of Aldolase a Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival","volume":"79","author":"Chang","year":"2019","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.bcp.2025.117499_b0635","article-title":"Aldolase a Accelerates Cancer Progression by Modulating mRNA translation and Protein Biosynthesis via Noncanonical Mechanisms","volume":"10","author":"Song","year":"2023","journal-title":"Adv Sci (weinh)."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0640","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41420-024-02249-z","article-title":"ALDOA contributes to colorectal tumorigenesis and metastasis by targeting YAP","volume":"10","author":"Sun","year":"2025","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b0645","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.31846","article-title":"Loss-of-Function Genetic Screening Identifies Aldolase a as an Essential driver for Liver Cancer Cell Growth under Hypoxia","volume":"74","author":"Niu","year":"2021","journal-title":"Hepatology"},{"issue":"39","key":"10.1016\/j.bcp.2025.117499_b0650","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41388-024-03134-w","article-title":"Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer","volume":"43","author":"Yu","year":"2024","journal-title":"Oncogene"},{"issue":"255","key":"10.1016\/j.bcp.2025.117499_b0655","article-title":"The antitumor role of a newly discovered \u03b1-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase a","volume":"1","author":"Wang","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bcp.2025.117499_b0660","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28166163","article-title":"Human Triosephosphate Isomerase is a potential Target in Cancer due to Commonly Occurring Post-Translational modifications","author":"Enr\u00edquez-Flores","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0665","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jmb.2009.09.062","article-title":"Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation","volume":"394","author":"Demarse","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0670","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.chembiol.2014.08.017","article-title":"Chemical targeting of GAPDH moonlighting function in cancer cells reveals its role in tubulin regulation","volume":"21","author":"Jung","year":"2014","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b0675","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1134\/S0006297917060013","article-title":"Role of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) in DNA Repair","volume":"82","author":"Kosova","year":"2017","journal-title":"Biochemistry (Mosc.)"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0680","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cmet.2017.08.017","article-title":"A Predictive Model for Selective Targeting of the Warburg effect through GAPDH Inhibition with a Natural Product","volume":"26","author":"Liberti","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117499_b0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103620","article-title":"Discovery of novel glyceraldehyde-3-phosphate dehydrogenase inhibitor via docking-based virtual screening","volume":"96","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0690","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41401-021-00653-0","article-title":"Natural product 1,2,3,4,6-penta-O-galloyl-\u03b2-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0695","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","article-title":"Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis","volume":"61","author":"Li","year":"2016","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0700","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","article-title":"Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy","volume":"65","author":"Qian","year":"2017","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0705","first-page":"2280","article-title":"PGK1-mediated cancer progression and drug resistance","volume":"9","author":"He","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0710","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","article-title":"O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth","volume":"11","author":"Nie","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0715","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/s41467-024-51232-w","article-title":"Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0720","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41401-020-0465-8","article-title":"Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52","volume":"42","author":"Wang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.117499_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114343","article-title":"Identification of a novel non-ATP-competitive protein kinase inhibitor of PGK1 from marine nature products","volume":"183","author":"Wang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"267","key":"10.1016\/j.bcp.2025.117499_b0730","article-title":"Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo","volume":"5","author":"He","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"244","key":"10.1016\/j.bcp.2025.117499_b0735","article-title":"Targeting PGAM1 in cancer: an emerging therapeutic opportunity","volume":"15","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"46","key":"10.1016\/j.bcp.2025.117499_b0740","doi-asserted-by":"crossref","first-page":"23264","DOI":"10.1073\/pnas.1914557116","article-title":"An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma","volume":"116","author":"Wen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"29","key":"10.1016\/j.bcp.2025.117499_b0745","article-title":"PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv Sci (weinh)."},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b0750","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cmet.2019.09.014","article-title":"A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer","volume":"30","author":"Huang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117499_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100957","article-title":"A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6\/JAK2\/STAT3 signaling pathway in lung adenocarcinoma","volume":"68","author":"Liang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0760","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1016\/j.apsb.2024.09.007","article-title":"A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.bcp.2025.117499_b0765","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fphar.2017.00325","article-title":"Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1","volume":"30","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b0770","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/molecules23061396","article-title":"The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"issue":"168","key":"10.1016\/j.bcp.2025.117499_b0775","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejmech.2019.01.085","article-title":"Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment","volume":"15","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0780","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.cmet.2021.11.011","article-title":"NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis","volume":"33","author":"Park","year":"2021","journal-title":"Cell Metab."},{"issue":"15","key":"10.1016\/j.bcp.2025.117499_b0785","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1158\/0008-5472.CAN-20-3543","article-title":"ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal transition","volume":"81","author":"Li","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0790","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-016-0385-8","article-title":"Alpha-enolase (ENO1) controls alpha v\/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis","volume":"10","author":"Principe","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"578","key":"10.1016\/j.bcp.2025.117499_b0795","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2021.09.027","article-title":"Upregulation of \u03b1 enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis","volume":"12","author":"Hou","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0800","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41419-020-03179-1","article-title":"Exosome-derived ENO1 regulates integrin \u03b16\u03b24 expression and promotes hepatocellular carcinoma growth and metastasis","volume":"11","author":"Jiang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0805","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/cancers12020311","article-title":"Cinnamaldehyde Enhances Antimelanoma activity through Covalently Binding ENO1 and Exhibits a Promoting effect with Dacarbazine","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0810","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s42255-020-00313-3","article-title":"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers","volume":"2","author":"Lin","year":"2020","journal-title":"Nat Metab."},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0815","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.15252\/embr.201643300","article-title":"PKM2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0820","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13105-024-01007-0","article-title":"The role of PKM2 in cancer progression and its structural and biological basis","volume":"80","author":"Wu","year":"2024","journal-title":"J. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0825","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117499_b0830","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.apsb.2024.04.024","article-title":"KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"42","key":"10.1016\/j.bcp.2025.117499_b0835","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0840","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/14756366.2017.1404591","article-title":"Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform","volume":"33","author":"Ning","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0845","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2011.10.039","article-title":"Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2","volume":"316","author":"Chen","year":"2012","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.bcp.2025.117499_b0850","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1111\/jcmm.14568","article-title":"Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation","volume":"23","author":"Pan","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0855","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.32756","article-title":"Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment","volume":"147","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"18","key":"10.1016\/j.bcp.2025.117499_b0860","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1021\/acs.jmedchem.9b00763","article-title":"Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors","volume":"62","author":"Hsieh","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b0865","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2013.09.025","article-title":"PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells","volume":"155","author":"Israelsen","year":"2013","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.bcp.2025.117499_b0870","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.7150\/ijbs.27854","article-title":"PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0875","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/ijms20092085","article-title":"Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells","volume":"20","author":"Urba\u0144ska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117499_b0880","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","article-title":"Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics","volume":"87","author":"Sharma","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002666","article-title":"KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase a (LDHA) and up-regulating H3K18 lactylation","volume":"22","author":"Hou","year":"2024","journal-title":"PLoS Biol."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2025.117499_b0890","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2022.09.001","article-title":"Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers","volume":"86","author":"Comandatore","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0895","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.bcp.2025.117499_b0900","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163022","article-title":"Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer","volume":"8","author":"Kitamura","year":"2023","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0905","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41419-021-03641-8","article-title":"LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma","volume":"12","author":"Hou","year":"2021","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.bcp.2025.117499_b0910","article-title":"Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention","volume":"11","author":"Yue","year":"2024","journal-title":"Adv Sci (weinh)."},{"issue":"8021","key":"10.1016\/j.bcp.2025.117499_b0915","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0920","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-9-33","article-title":"Warburg effect in chemosensitivity: targeting lactate dehydrogenase-a re-sensitizes taxol-resistant cancer cells to taxol","volume":"9","author":"Zhou","year":"2010","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2025.117499_b0925","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nchembio.2143","article-title":"Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition","volume":"12","author":"Boudreau","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"240","key":"10.1016\/j.bcp.2025.117499_b0930","article-title":"Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment","volume":"5","author":"Di Magno","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0935","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cbpa.2012.12.022","article-title":"Target deconvolution techniques in modern phenotypic profiling","volume":"17","author":"Lee","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b0940","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0945","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1002\/ctm2.588","article-title":"Therapeutic targeting of SPIB\/SPI1-facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23864","article-title":"Target-based drug discovery: applications of fluorescence techniques in high throughput and fragment-based screening","volume":"10","author":"Kumar","year":"2023","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.bcp.2025.117499_b0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003554","article-title":"Towards structural systems pharmacology to study complex diseases and personalized medicine","volume":"10","author":"Xie","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b0960","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1038\/s41596-023-00885-w","article-title":"A practical guide to machine-learning scoring for structure-based virtual screening","volume":"18","author":"Tran-Nguyen","year":"2023","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0965","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/med.21377","article-title":"Strategies for the Optimization of Natural leads to Anticancer Drugs or Drug Candidates","volume":"36","author":"Xiao","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"25","key":"10.1016\/j.bcp.2025.117499_b0970","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/bi3005126","article-title":"Fragment-based approaches in drug discovery and chemical biology","volume":"51","author":"Scott","year":"2012","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b0975","article-title":"Non-Extensive Fragmentation of Natural Products and Pharmacophore-based Virtual Screening as a Practical Approach to Identify Novel Promising Chemical Scaffolds","volume":"2","author":"V\u00e1squez","year":"2021","journal-title":"Front. Chem."},{"issue":"138","key":"10.1016\/j.bcp.2025.117499_b0980","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2017.06.064","article-title":"Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase","volume":"29","author":"Ning","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0985","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/biomedicines12010201","article-title":"Anticancer Drug Discovery based on Natural Products: from Computational Approaches to Clinical Studies","volume":"12","author":"Chunarkar-Patil","year":"2024","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b0990","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b0995","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/acs.jmedchem.2c01505","article-title":"Discovery of the first Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer","volume":"66","author":"Sun","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b1000","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.bcp.2025.117499_b1005","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2025.117499_b1010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.bcp.2025.117499_b1015","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.tibtech.2018.06.008","article-title":"Chemoproteomics and Chemical Probes for Target Discovery","volume":"36","author":"Drewes","year":"2018","journal-title":"Trends Biotechnol."},{"issue":"223","key":"10.1016\/j.bcp.2025.117499_b1020","article-title":"Label-free target protein characterization for small molecule drugs: recent advances in methods and applications","volume":"20","author":"Feng","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b1025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.chembiol.2019.11.010","article-title":"Identification of a small compound Targeting PKM2-Regulated Signaling using 2D Gel Electrophoresis-based Proteome-wide CETSA","volume":"27","author":"Nagasawa","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117499_b1030","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.2147\/OTT.S316597","article-title":"Circular RNAs Regulate Glucose Metabolism in Cancer Cells","volume":"2","author":"Ji","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"19","key":"10.1016\/j.bcp.2025.117499_b1035","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.3390\/cancers14194568","article-title":"Targeting Glucose Metabolism Enzymes in Cancer Treatment: current and Emerging strategies","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7858","key":"10.1016\/j.bcp.2025.117499_b1040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumor microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117499_b1045","doi-asserted-by":"crossref","unstructured":"Ferrucci PF, Di Giacomo AM, Del Vecchio M, Atkinson V, Schmidt H, Schachter J, Queirolo P, Long GV, Stephens R, Svane IM, Lotem M, Abu-Amna M, Gasal E, Ghori R, Diede SJ, Croydon ES, Ribas A, Ascierto PA; KEYNOTE-022 international team. KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma. J Immunother Cancer. 2020 Dec;8(2):e001806.","DOI":"10.1136\/jitc-2020-001806"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b1050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic Heterogeneity in Human Lung Tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.bcp.2025.117499_b1055","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.21037\/atm-20-1114","article-title":"Metabolic programming of tumor associated macrophages in the context of cancer treatment","volume":"8","author":"Crezee","year":"2020","journal-title":"Ann Transl Med."},{"issue":"7678","key":"10.1016\/j.bcp.2025.117499_b1060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b1065","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1158\/0008-5472.CAN-19-3020","article-title":"Serine Biosynthesis is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression","volume":"81","author":"Barnabas","year":"2021","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.bcp.2025.117499_b1070","doi-asserted-by":"crossref","first-page":"37281","DOI":"10.18632\/oncotarget.6134","article-title":"Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression","volume":"6","author":"Chaube","year":"2015","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.bcp.2025.117499_b1075","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.2147\/IJN.S140462","article-title":"Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment","volume":"4","author":"Graham","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bcp.2025.117499_b1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101410","article-title":"Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells","volume":"55","author":"Trinh","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2025.117499_b1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b1090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neo.2020.12.009","article-title":"Glycolysis-induced drug resistance in tumors-a response to danger signals?","volume":"23","author":"Marcucci","year":"2021","journal-title":"Neoplasia"},{"issue":"14","key":"10.1016\/j.bcp.2025.117499_b1095","article-title":"Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation","volume":"29","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117499_b1100","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","article-title":"Lactylation in cancer: current understanding and challenges","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bcp.2025.117499_b1105","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","article-title":"The role of protein lactylation: a kaleidoscopic post-translational modification in cancer","volume":"85","author":"Iozzo","year":"2025","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b1110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41556-025-01635-8","article-title":"Emerging roles of lysine lactyltransferases and lactylation","volume":"27","author":"Zong","year":"2025","journal-title":"Nat. Cell Biol."},{"issue":"18","key":"10.1016\/j.bcp.2025.117499_b1115","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.3390\/ijms231810263","article-title":"Simultaneous probing of Metabolism and Oxygenation of Tumors In Vivo using FLIM of NAD(P)H and PLIM of a New Polymeric Ir(III) Oxygen Sensor","volume":"23","author":"Parshina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b1120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117499_b1125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","article-title":"Mitochondrial diseases: from molecular mechanisms to therapeutic advances","volume":"10","author":"Wen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b1130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11427-023-2369-3","article-title":"Modeling drug-induced mitochondrial toxicity with human primary cardiomyocytes","volume":"67","author":"Tang","year":"2024","journal-title":"Sci. China Life Sci."},{"issue":"268","key":"10.1016\/j.bcp.2025.117499_b1135","article-title":"Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells","volume":"15","author":"Helmy","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117499_b1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116221","article-title":"Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction","volume":"224","author":"Thi Thanh Nguyen","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117499_b1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116456","article-title":"Furanodienone induces apoptosis via regulating the PRDX1\/MAPKs\/p53\/caspases signaling axis through NOX4-derived mitochondrial ROS in colorectal cancer cells","volume":"227","author":"Jiang","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b1150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13167-024-00358-4","article-title":"Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation","volume":"15","author":"Golubnitschaja","year":"2024","journal-title":"EPMA J."},{"issue":"3","key":"10.1016\/j.bcp.2025.117499_b1155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13167-020-00217-y","article-title":"Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism","volume":"11","author":"Samec","year":"2020","journal-title":"EPMA J."},{"issue":"4","key":"10.1016\/j.bcp.2025.117499_b1160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s13167-024-00385-1","article-title":"Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches","volume":"15","author":"Li","year":"2024","journal-title":"EPMA J."},{"issue":"6","key":"10.1016\/j.bcp.2025.117499_b1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189023","article-title":"Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.117499_b1170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13167-024-00357-5","article-title":"Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine","volume":"15","author":"Bajinka","year":"2024","journal-title":"EPMA J."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:03:41Z","timestamp":1775797421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":234,"alternative-id":["S0006295225007646"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117499","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting glycolytic enzymes to combat cancer metastasis: Strategies toward clinical translation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117499"}}